Get the Stockscreener App
6.11
4.53%
-0.29
Achieve Life Sciences Inc stock is traded at $6.11, with a volume of 2.05M.
It is down -4.53% in the last 24 hours and up +6.26% over the past month.
Achieve Life Sciences Inc is a late-stage clinical specialty pharmaceutical company with the sole mission to address the nicotine dependence epidemic through the development and commercialization of cytisinicline. Cytisinicline, is a naturally occurring alkaloid. Additionally, The company has completed a Phase 2 study with cytisinicline in vaping cessation and conducted a successful end-of-Phase 2 meeting with the FDA for a future vaping indication. It operates in one operating segment, development and commercialization of cytisinicline for nicotine dependence, with operations located in Canada, the United States and the U.K.
See More
Previous Close:
$6.40
Open:
$6.37
24h Volume:
2.05M
Relative Volume:
1.04
Market Cap:
$627.25M
Revenue:
-
Net Income/Loss:
$-54.65M
P/E Ratio:
-4.7189
EPS:
-1.2948
Net Cash Flow:
$-49.47M
1W Performance:
-4.53%
1M Performance:
+6.26%
6M Performance:
+9.89%
1Y Performance:
+162.23%
1-Day Range:
$5.81
$6.40
1-Week Range:
$5.81
$6.66
52-Week Range:
$2.25
$7.11
Achieve Life Sciences Inc Stock (ACHV) Company Profile
Name
Achieve Life Sciences Inc
Sector
Industry
Phone
425-686-1500
Address
22722 29TH DR. SE, SEATTLE, BC
Compare ACHV vs VRTX, REGN, ARGX, ALNY, RVMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACHV
Achieve Life Sciences Inc
|
6.11 | 627.25M | 0 | -54.65M | -49.47M | -1.2948 |
VRTX
Vertex Pharmaceuticals Inc
|
485.39 | 123.19B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
664.52 | 69.67B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
877.62 | 54.58B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
298.76 | 39.89B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
186.88 | 39.73B | 742.00K | -1.37B | -1.07B | -7.0731 |
Achieve Life Sciences Inc Stock (ACHV) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-21-26 | Initiated | Canaccord Genuity | Buy |
| Nov-25-25 | Initiated | Citizens JMP | Mkt Outperform |
| Aug-21-25 | Initiated | H.C. Wainwright | Buy |
| Nov-14-24 | Initiated | Rodman & Renshaw | Buy |
| Sep-27-24 | Initiated | Raymond James | Strong Buy |
| May-10-23 | Reiterated | Maxim Group | Buy |
| Jun-23-21 | Initiated | Oppenheimer | Outperform |
View All
Achieve Life Sciences Inc Stock (ACHV) Latest News
ACHV Stock On Track To For Best Day In Over 7 Years — What’s Driving The Rally? - Stocktwits
Achieve Life Sciences (NASDAQ:ACHV) Trading Down 7.7%Should You Sell? - MarketBeat
Achieve Life Sciences Stockholders Weigh Board Slate, Share Increase at Annual Meeting - Yahoo Finance
Achieve Life Sciences Inc. (ACHV) Stock Price | Live Quotes & Charts | NASDAQ - timothysykes.com
Vivo Opportunity group reports 5.0% stake in Achieve Life Sciences | ACHV SEC FilingForm SCHEDULE 13G - Stock Titan
Achieve Life Sciences Joins Russell 2000 Index - 富途牛牛
Achieve Life Sciences: Despite CRL, A Success Is Achieve-Able (NASDAQ:ACHV) - Seeking Alpha
Achieve Life Sciences, Inc. Amends Certificate of Incorporation – SEC 8-K Filing Details and Company Information - Minichart
[8-K] ACHIEVE LIFE SCIENCES, INC. Reports Material Event - Stock Titan
ACHVAchieve Life Sciences Inc Latest SEC Filings - Finviz
Achieve Life Sciences Inc Annual Shareholders Meeting Transcript - GuruFocus
Achieve Life Sciences, Inc.(NasdaqCM:ACHV) added to Russell Small Cap Comp Growth Benchmark - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2500 Growth Benchmark - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2000 Index - marketscreener.com
Achieve Life Sciences added to Russell 2000 index By Investing.com - Investing.com Nigeria
Achieve Life Sciences (ACHV) Joins Russell 2000 Index - GuruFocus
Achieve Life Sciences added to Russell 2000 index - Investing.com
Achieve Life Sciences Joins Russell 2000® Index - The Manila Times
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2000 Growth Benchmark - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 3000E Index - marketscreener.com
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 3000E Growth Benchmark - marketscreener.com
Enterprise value to revenue forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Enterprise value to EBIT forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Price to earnings forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Achieve Life Sciences, Inc.(NasdaqCM: ACHV) added to Russell 2500 Index - marketscreener.com
Price to sales forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Enterprise value to EBITDA forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Price to book forward of Achieve Life Sciences, Inc. – NASDAQ:ACHV - TradingView
Achieve Life Sciences, Inc.(NasdaqCM:ACHV) added to Russell Small Cap Completeness Index - marketscreener.com
Achieve Life Sciences (ACHV) Receives Strong Buy Rating with $20 Target - GuruFocus
Raymond James resumes Achieve Life Sciences stock coverage with Strong Buy - Investing.com Canada
Achieve Life Sciences, Inc. Actuals & Estimates (NASDAQ:ACHV) - TradingView
Achieve Life Sciences, Inc. Actuals & Estimates (MUN:SP4P) - TradingView
ACHV Forecast — Price Target — Prediction for 2027 - TradingView
Achieve Life Sciences Inc (ACHV) Valuation: PE, PB & Fair Value Analysis - TradingKey
Achieve Life Sciences (ACHV) Receives a Buy from Canaccord Genuity - The Globe and Mail
Canaccord reiterates Achieve Life Sciences stock rating after CRL By Investing.com - Investing.com India
Canaccord reiterates Achieve Life Sciences stock rating after CRL - Investing.com
Wainwright reiterates Achieve Life Sciences stock rating after FDA letter - Investing.com
Wainwright reiterates Achieve Life Sciences stock rating after FDA letter By Investing.com - Investing.com India
Achieve Life Sciences: CRL Is Fixable, So I Remain Bullish - Seeking Alpha
Achieve Life Sciences jumps despite cytisinicline CRL - MSN
FDA Declines To Approve Achieve Life Sciences' Smoking Cessation Drug; Q4 Resubmission Planned - Sahm
Achieve Life Sciences (ACHV) Receives FDA Complete Response Lett - GuruFocus
Achieve Life Sciences stock falls after FDA issues response letter - Investing.com
ACHV Reiterated by HC Wainwright & Co. -- Price Target Maintained at $12 - GuruFocus
Achieve Life Sciences (ACHV) Sees 10% Rise Despite FDA Complete Response Letter - GuruFocus
FDA Issues Complete Response Letter for Cytisinicline NDA, Citing Manufacturing Deficiencies - AJMC
US FDA declines to approve Achieve Life Sciences' smoking-cessation drug - Reuters
Achieve Life Sciences Shares Rise After Complete Response Letter From FDA - marketscreener.com
Achieve Life Sciences Receives FDA Complete Response Letter for Cytisinicline - marketscreener.com
Achieve Life Sciences Inc Stock (ACHV) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.64%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):